Active

H & H PHARMACEUTICALS

Switched

BE0759775660

Rechtspersoon Private limited company 1 establishment

Avenue Thomas Edison 105, 1402 Nivelles Groothandel in farmaceutische en medische artikelen

Active for

5 year, 8 months

Financials

Financial year 2025

Revenue

€ 1.7 million

▼ 4% vs 2024

Profit

Growing

€ 8.4 million

▲ 144% vs 2024

Debts

Low

€ 19.6 million

▼ 12% vs 2024

H & H PHARMACEUTICALS from Nivelles, company number BE0759775660, closed financial year 2025 with a result of € 8.4 million after tax. For that financial year H & H PHARMACEUTICALS recorded revenue of € 1.7 million and equity of € 27.8 million. Compared with financial year 2024, the result moved from € 3.4 million to € 8.4 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 20, 2026.

What happened at H & H PHARMACEUTICALS?

What happened at H & H PHARMACEUTICALS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 8.4 million (▲ 144% vs 2024). filed late Source: NBB ↗
  • New establishment in Nivelles. KBO
  • Start of the company according to the CBE. KBO

In short

From € 328,488 loss in 2021 to € 8.4 million profit in 2025.

Paid € 127,807 in corporate taxes since 2021.

Best year ever: 2023, with € 13.9 million profit.

Pays suppliers within 44 days on average.

A new publication or filing at H & H PHARMACEUTICALS? We notify you, reason included.

Follow H & H PHARMACEUTICALS

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Laurent HAVERBEKE
Koen SMESSAERT
H & H PHARMACEUTICALS
FUSION MEDICARE 100%
Soneprophar 96%
EXPHAR.CH 95%
EXPHAR 93.7%

Behind H & H PHARMACEUTICALS are Laurent HAVERBEKE and Koen SMESSAERT. It owns 100% of FUSION MEDICARE, 96% of Soneprophar, 95% of EXPHAR.CH and 93.7% of EXPHAR itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Laurent HAVERBEKE

Director

Also active at: LHVK

Koen SMESSAERT

Director

Also active at: IPM ADVICE

Establishments

Establishment units

Physical locations of this company

Registered office

Avenue Thomas Edison 105

1402 Nivelles

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

Details

Company number
0759.775.660
VAT number
BE 0759.775.660
Registered office
Avenue Thomas Edison 105, 1402 Nivelles
Names & denominations
H & H PHARMACEUTICALS
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
14 December 2020
Peppol
Active · Active since 1 Jan 2001
Activities · NACE

Groothandel in farmaceutische en medische artikelen

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Opslag

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Frequently asked questions

What is the enterprise number of H & H PHARMACEUTICALS?
The enterprise number of H & H PHARMACEUTICALS is BE0759775660.
What is the address of H & H PHARMACEUTICALS?
The registered office of H & H PHARMACEUTICALS is located at Avenue Thomas Edison 105, 1402 Nivelles.
When was H & H PHARMACEUTICALS founded?
H & H PHARMACEUTICALS was founded on 14 December 2020.
What is the main activity of H & H PHARMACEUTICALS?
The main activity of H & H PHARMACEUTICALS is "Groothandel in farmaceutische en medische artikelen" (NACE code 46460).
Does H & H PHARMACEUTICALS have a website?
No website is currently known for H & H PHARMACEUTICALS.
How much profit did H & H PHARMACEUTICALS make in 2025?
H & H PHARMACEUTICALS posted a profit after taxes of € 8,357,527 in financial year 2025.
What is the revenue of H & H PHARMACEUTICALS?
In its most recent annual accounts (2025), H & H PHARMACEUTICALS reported revenue of € 1,671,876.
Where can I find the annual accounts of H & H PHARMACEUTICALS?
H & H PHARMACEUTICALS files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of H & H PHARMACEUTICALS?
According to the 2025 annual accounts, the directors of H & H PHARMACEUTICALS are: Laurent HAVERBEKE, Koen SMESSAERT.
Who owns H & H PHARMACEUTICALS?
Behind H & H PHARMACEUTICALS are Laurent HAVERBEKE and Koen SMESSAERT. It owns 100% of FUSION MEDICARE, 96% of Soneprophar, 95% of EXPHAR.CH and 93.7% of EXPHAR itself.